Pre-market Hot Trades in US Stocks
Waldencast, down 7.44% in pre-market trading, has no significant recent news. The trading is active, with clear capital flows. Considering the trends in sectors and industries, the stock shows significant volatility, and the specific reasons need further observation.
Entravision is up 4.01% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 6, Entravision announced its first-quarter financial report, showing a return to profitability and a significant increase in revenue from its advertising technology business. The company reported a net profit of $12.36 million, a significant improvement from a loss in the same period last year, driving the stock price up. Source: WSJ
</li>
<li>
On May 6, Entravision is well-positioned in the political advertising spending environment and is expected to benefit from major state election advertising spending in 2026. Political advertising is a key revenue source for US media companies during election cycles, driving the stock price up. Source: Reuters
</li>
<li>
On May 6, Entravision's advertising technology and services division saw operating profits surge to $34.3 million, offsetting losses in the traditional media division and boosting investor confidence. Source: Benzinga The advertising technology industry is growing rapidly, with increased political advertising spending.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Global Engine is up 92% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 6, Global Engine Group Holding Ltd. announced its strategic expansion plan in the Hong Kong market. This plan includes adding new product lines and expanding market share, significantly driving up the stock price. According to GlobeNewswire, the company plans to launch multiple new products in the coming year and strengthen its relationships with existing customers, further consolidating its market position.
</li>
<li>
On May 5, analysts gave a positive evaluation of Global Engine's future growth potential. Several well-known brokerages released reports stating that the company has significant advantages in technological innovation and market expansion, and its stock price is expected to continue rising. Analysts pointed out that Global Engine's investment in R&amp;D and market strategies will provide it with long-term competitive advantages.
</li>
<li>
On May 4, macroeconomic data supported market optimism. Economic data from Hong Kong and the US showed strong performance, boosting investor confidence and driving related stocks up. In particular, the clear signs of economic recovery in the Hong Kong market further stimulated investor interest in Global Engine. The industry expansion plan drives the stock price up.
</li>
</ol>
Agilon Health is up 56.23% in pre-market trading. Based on recent news,
<ol>
<li>
On May 4, JP Morgan downgraded agilon health's rating from &#34;Neutral&#34; to &#34;Underweight,&#34; with a target price of $21. The brokerage pointed out that rising healthcare utilization rates and high execution risks require management to rebuild credibility. This led to a 7.5% drop in the stock price
</li>
<li>
On May 6, Agilon Health announced a net income of $49 million for the first quarter, far exceeding market expectations of $11.6 million, with adjusted EBITDA of $54 million, higher than the expected $34.9 million. This positive news drove the stock price up.
</li>
<li>
On May 7, Agilon Health's stock closed at $27.85, with analysts having mixed views on the stock, but overall market sentiment was relatively positive. The healthcare industry performed well overall, and investor sentiment was optimistic.
</li>
</ol>
Atara Biotherapeutics pre-market rose 54.56%. Based on recent key news:
<ol>
<li>
On May 6, Atara Biotherapeutics is set to announce its Q1 2026 financial report, with market expectations of revenue at $2.9 million and earnings per share at -$0.33. Investors are optimistic about the upcoming financial report, driving the stock price significantly higher. Source: FactSet
</li>
<li>
On May 6, Atara Biotherapeutics faced a class-action lawsuit involving former employees and shareholders. Although legal issues may bring uncertainty, market expectations for the company's financial performance still dominated the stock price movement. Source: Faruq &amp; Faruq, LLP
</li>
<li>
On May 7, Rosen Law Firm announced that investors have the opportunity to lead a securities fraud lawsuit against Atara Biotherapeutics. Despite the legal risks, investor confidence in the company's future performance has not been significantly affected. Source: Rosen Law Firm, P.A. The biotechnology industry has been volatile recently and requires attention
</li>
</ol>

WALD

Waldencast pre-market down 7.44%; Entravision Comm pre-market up 4.01%; Global Engine pre-market up 92.05%; agilon health pre-market up 56.23%; Atara Biotherapeutics pre-market up 54.56%

Price Alert

Waldencast

Pre-market hot trades in US stocks: Waldencast pre-market down 7.44%; Entravision Comm pre-market up 4.01%